PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio.\', \'Department of Pharmacy, Cleveland Clinic, Cleveland, Ohio.\', \'Department of Infectious Diseases, Hillcrest Hospital, Cleveland, Ohio.\', \'Department of Rheumatologic and Immunologic Disease, Cleveland Clinic, Ohio.\', \'Department of Critical Care Medicine, Cleveland Clinic, Cleveland, Ohio.\', \'Department of Pulmonary Medicine, Cleveland Clinic, Cleveland, Ohio.\', \'Transplantation Center, Cleveland Clinic, Cleveland, Ohio.\', \'Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, Ohio.\', \'Department of Hepatology, Cleveland Clinic, Cleveland, Ohio.\', \'Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/ajt.16080
?:doi
?:hasPublicationType
?:journal
  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
is ?:pmid of
?:pmid
?:pmid
  • 32476261
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Tocilizumab therapy in 5 solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all